Cargando…
Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate
Modulating the gut microbiota composition is a potent approach to treat various chronic diseases, including obesity, metabolic syndrome, and ulcerative colitis (UC). However, the current methods, such as fecal microbiota transplantation, carry a risk of serious infections due to the transmission of...
Autores principales: | Yang, Chunhua, Sung, Junsik, Long, Dingpei, Alghoul, Zahra, Merlin, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228491/ https://www.ncbi.nlm.nih.gov/pubmed/35745805 http://dx.doi.org/10.3390/pharmaceutics14061233 |
Ejemplares similares
-
Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles
por: Long, Dingpei, et al.
Publicado: (2023) -
Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome
por: Yang, Chunhua, et al.
Publicado: (2021) -
Impact of PepT1 deletion on microbiota composition and colitis requires multiple generations
por: Viennois, Emilie, et al.
Publicado: (2020) -
Preparation and Characterization of IL-22 mRNA-loaded Lipid Nanoparticles
por: Alghoul, Zahra, et al.
Publicado: (2023) -
CD101 inhibits the expansion of colitogenic T cells
por: Schey, Regina, et al.
Publicado: (2016)